J F Baumrucker. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Drug InteractionsErgot Alkaloids/administration & dosageErgot Alkaloids/adverse effectsErgot Alkaloids/therapeutic useHumansMaleMiddle AgedMigraine Disorders/prevention & controlPropranolol/administration & dosagePropranolol/adverse effectsPropranolol/therapeutic useSuppositoriesVasoconstrictor Agents/administration & dosageVasoconstrictor Agents/adverse effectsVasoconstrictor Agents/therapeutic use
Substances: See more » Ergot AlkaloidsSuppositoriesVasoconstrictor AgentsPropranolol
Year: 1973 PMID: 4693950
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245